 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cytokine(chemotactic)
|
PDB id
|
|
|
|
1hum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
10 terms
|
 |
|
Biochemical function
|
cytokine activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
263:1762-1767
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
High-resolution solution structure of the beta chemokine hMIP-1 beta by multidimensional NMR.
|
|
P.J.Lodi,
D.S.Garrett,
J.Kuszewski,
M.L.Tsang,
J.A.Weatherbee,
W.J.Leonard,
A.M.Gronenborn,
G.M.Clore.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The three-dimensional structure of a member of the beta subfamily of chemokines,
human macrophage inflammatory protein-1 beta (hMIP-1 beta), has been determined
with the use of solution multidimensional heteronuclear magnetic resonance
spectroscopy. Human MIP-1 beta is a symmetric homodimer with a relative
molecular mass of approximately 16 kilodaltons. The structure of the hMIP-1 beta
monomer is similar to that of the related alpha chemokine interleukin-8 (IL-8).
However, the quaternary structures of the two proteins are entirely distinct,
and the dimer interface is formed by a completely different set of residues.
Whereas the IL-8 dimer is globular, the hMIP-1 beta dimer is elongated and
cylindrical. This provides a rational explanation for the absence of
cross-binding and reactivity between the alpha and beta chemokine subfamilies.
Calculation of the solvation free energies of dimerization suggests that the
formation and stabilization of the two different types of dimers arise from the
burial of hydrophobic residues.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.L.Salanga,
and
T.M.Handel
(2011).
Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.
|
| |
Exp Cell Res, 317,
590-601.
|
 |
|
|
|
|
 |
O.Chertov,
N.Zhang,
X.Chen,
J.J.Oppenheim,
J.Lubkowski,
C.McGrath,
R.C.Sowder,
B.J.Crise,
A.Malyguine,
M.A.Kutzler,
A.D.Steele,
E.E.Henderson,
and
T.J.Rogers
(2011).
Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture.
|
| |
PLoS One, 6,
e14474.
|
 |
|
|
|
|
 |
Y.S.Kang,
J.J.Cha,
Y.Y.Hyun,
and
D.R.Cha
(2011).
Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
|
| |
Expert Opin Investig Drugs, 20,
745-756.
|
 |
|
|
|
|
 |
K.J.Metzger,
and
M.A.Thomas
(2010).
Evidence of positive selection at codon sites localized in extracellular domains of mammalian CC motif chemokine receptor proteins.
|
| |
BMC Evol Biol, 10,
139.
|
 |
|
|
|
|
 |
M.Ren,
Q.Guo,
L.Guo,
M.Lenz,
F.Qian,
R.R.Koenen,
H.Xu,
A.B.Schilling,
C.Weber,
R.D.Ye,
A.R.Dinner,
and
W.J.Tang
(2010).
Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme.
|
| |
EMBO J, 29,
3952-3966.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Colobran,
E.Pedrosa,
L.Carretero-Iglesia,
and
M.Juan
(2010).
Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.
|
| |
Clin Exp Immunol, 162,
41-52.
|
 |
|
|
|
|
 |
S.T.Das,
L.Rajagopalan,
A.Guerrero-Plata,
J.Sai,
A.Richmond,
R.P.Garofalo,
and
K.Rajarathnam
(2010).
Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment.
|
| |
PLoS One, 5,
e11754.
|
 |
|
|
|
|
 |
E.Viey,
C.Lucas,
F.Romagne,
B.Escudier,
S.Chouaib,
and
A.Caignard
(2008).
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vgamma9Vdelta2 T cells from renal cell carcinoma patients.
|
| |
J Immunother, 31,
313-323.
|
 |
|
|
|
|
 |
J.R.Larrubia,
S.Benito-Martínez,
M.Calvino,
E.Sanz-de-Villalobos,
and
T.Parra-Cid
(2008).
Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection.
|
| |
World J Gastroenterol, 14,
7149-7159.
|
 |
|
|
|
|
 |
L.Vangelista,
M.Secchi,
and
P.Lusso
(2008).
Rational design of novel HIV-1 entry inhibitors by RANTES engineering.
|
| |
Vaccine, 26,
3008-3015.
|
 |
|
|
|
|
 |
T.Jabeen,
P.Leonard,
H.Jamaluddin,
and
K.R.Acharya
(2008).
Structure of mouse IP-10, a chemokine.
|
| |
Acta Crystallogr D Biol Crystallogr, 64,
611-619.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Allen,
S.E.Crown,
and
T.M.Handel
(2007).
Chemokine: receptor structure, interactions, and antagonism.
|
| |
Annu Rev Immunol, 25,
787-820.
|
 |
|
|
|
|
 |
S.Kim,
J.Tsai,
I.Kagiampakis,
P.LiWang,
and
M.Vannucci
(2007).
Detecting protein dissimilarities in multiple alignments using Bayesian variable selection.
|
| |
Bioinformatics, 23,
245-246.
|
 |
|
|
|
|
 |
T.Cardozo,
T.Kimura,
S.Philpott,
B.Weiser,
H.Burger,
and
S.Zolla-Pazner
(2007).
Structural basis for coreceptor selectivity by the HIV type 1 V3 loop.
|
| |
AIDS Res Hum Retroviruses, 23,
415-426.
|
 |
|
|
|
|
 |
L.Rajagopalan,
and
K.Rajarathnam
(2006).
Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.
|
| |
Biosci Rep, 26,
325-339.
|
 |
|
|
|
|
 |
L.Zhang,
M.Derider,
M.A.McCornack,
S.C.Jao,
N.Isern,
T.Ness,
R.Moyer,
and
P.J.LiWang
(2006).
Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1beta.
|
| |
Proc Natl Acad Sci U S A, 103,
13985-13990.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Y.Springael,
E.Urizar,
and
M.Parmentier
(2005).
Dimerization of chemokine receptors and its functional consequences.
|
| |
Cytokine Growth Factor Rev, 16,
611-623.
|
 |
|
|
|
|
 |
K.Princen,
and
D.Schols
(2005).
HIV chemokine receptor inhibitors as novel anti-HIV drugs.
|
| |
Cytokine Growth Factor Rev, 16,
659-677.
|
 |
|
|
|
|
 |
A.Bhaduri,
R.Ravishankar,
and
R.Sowdhamini
(2004).
Conserved spatially interacting motifs of protein superfamilies: application to fold recognition and function annotation of genome data.
|
| |
Proteins, 54,
657-670.
|
 |
|
|
|
|
 |
O.A.Asojo,
C.Boulègue,
D.M.Hoover,
W.Lu,
and
J.Lubkowski
(2003).
Structures of thymus and activation-regulated chemokine (TARC).
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
1165-1173.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.J.Fernandez,
and
E.Lolis
(2002).
Structure, function, and inhibition of chemokines.
|
| |
Annu Rev Pharmacol Toxicol, 42,
469-499.
|
 |
|
|
|
|
 |
M.K.Schwarz,
and
T.N.Wells
(2002).
New therapeutics that modulate chemokine networks.
|
| |
Nat Rev Drug Discov, 1,
347-358.
|
 |
|
|
|
|
 |
P.Menten,
A.Wuyts,
and
J.Van Damme
(2002).
Macrophage inflammatory protein-1.
|
| |
Cytokine Growth Factor Rev, 13,
455-481.
|
 |
|
|
|
|
 |
C.Baysal,
and
A.R.Atilgan
(2001).
Elucidating the structural mechanisms for biological activity of the chemokine family.
|
| |
Proteins, 43,
150-160.
|
 |
|
|
|
|
 |
M.Crow,
D.D.Taub,
S.Cooper,
H.E.Broxmeyer,
and
A.H.Sarris
(2001).
Human recombinant interferon-inducible protein-10: intact disulfide bridges are not required for inhibition of hematopoietic progenitors and chemotaxis of T lymphocytes and monocytes.
|
| |
J Hematother Stem Cell Res, 10,
147-156.
|
 |
|
|
|
|
 |
W.Shao,
E.Fernandez,
A.Sachpatzidis,
J.Wilken,
D.A.Thompson,
B.I.Schweitzer,
and
E.Lolis
(2001).
CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure.
|
| |
Eur J Biochem, 268,
2948-2959.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Buyong,
J.Xiong,
J.Lubkowski,
and
R.Nussinov
(2000).
Homology modeling and molecular dynamics simulations of lymphotactin.
|
| |
Protein Sci, 9,
2192-2199.
|
 |
|
|
|
|
 |
J.Blaszczyk,
E.V.Coillie,
P.Proost,
J.V.Damme,
G.Opdenakker,
G.D.Bujacz,
J.M.Wang,
and
X.Ji
(2000).
Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors.
|
| |
Biochemistry, 39,
14075-14081.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.S.Laurence,
C.Blanpain,
J.W.Burgner,
M.Parmentier,
and
P.J.LiWang
(2000).
CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding.
|
| |
Biochemistry, 39,
3401-3409.
|
 |
|
|
|
|
 |
J.T.Ashfield,
T.Meyers,
D.Lowne,
P.G.Varley,
J.R.Arnold,
P.Tan,
J.C.Yang,
L.G.Czaplewski,
T.Dudgeon,
and
J.Fisher
(2000).
Chemical modification of a variant of human MIP-1alpha; implications for dimer structure.
|
| |
Protein Sci, 9,
2047-2053.
|
 |
|
|
|
|
 |
K.Huang,
J.M.Louis,
L.Donaldson,
F.L.Lim,
A.D.Sharrocks,
and
G.M.Clore
(2000).
Solution structure of the MEF2A-DNA complex: structural basis for the modulation of DNA bending and specificity by MADS-box transcription factors.
|
| |
EMBO J, 19,
2615-2628.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.C.LiWang,
J.J.Cao,
H.Zheng,
Z.Lu,
S.C.Peiper,
and
P.J.LiWang
(1999).
Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein.
|
| |
Biochemistry, 38,
442-453.
|
 |
|
|
|
|
 |
A.C.Liwang,
Z.X.Wang,
Y.Sun,
S.C.Peiper,
and
P.J.Liwang
(1999).
The solution structure of the anti-HIV chemokine vMIP-II.
|
| |
Protein Sci, 8,
2270-2280.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Lala,
M.Gwinn,
and
E.De Nardin
(1999).
Human formyl peptide receptor function role of conserved and nonconserved charged residues.
|
| |
Eur J Biochem, 264,
495-499.
|
 |
|
|
|
|
 |
E.Van Coillie,
J.Van Damme,
and
G.Opdenakker
(1999).
The MCP/eotaxin subfamily of CC chemokines.
|
| |
Cytokine Growth Factor Rev, 10,
61-86.
|
 |
|
|
|
|
 |
H.Sticht,
S.E.Escher,
K.Schweimer,
W.G.Forssmann,
P.Rösch,
and
K.Adermann
(1999).
Solution structure of the human CC chemokine 2: A monomeric representative of the CC chemokine subtype.
|
| |
Biochemistry, 38,
5995-6002.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.S.Mizoue,
J.F.Bazan,
E.C.Johnson,
and
T.M.Handel
(1999).
Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1.
|
| |
Biochemistry, 38,
1402-1414.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Dealwis,
E.J.Fernandez,
D.A.Thompson,
R.J.Simon,
M.A.Siani,
and
E.Lolis
(1998).
Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor.
|
| |
Proc Natl Acad Sci U S A, 95,
6941-6946.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.S.Laurence,
A.C.LiWang,
and
P.J.LiWang
(1998).
Effect of N-terminal truncation and solution conditions on chemokine dimer stability: nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1 beta mutants.
|
| |
Biochemistry, 37,
9346-9354.
|
 |
|
|
|
|
 |
W.Shao,
L.F.Jerva,
J.West,
E.Lolis,
and
B.I.Schweitzer
(1998).
Solution structure of murine macrophage inflammatory protein-2.
|
| |
Biochemistry, 37,
8303-8313.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.J.Doranz,
J.F.Berson,
J.Rucker,
and
R.W.Doms
(1997).
Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1).
|
| |
Immunol Res, 16,
15-28.
|
 |
|
|
|
|
 |
F.Coulin,
C.A.Power,
S.Alouani,
M.C.Peitsch,
J.M.Schroeder,
M.Moshizuki,
I.Clark-Lewis,
and
T.N.Wells
(1997).
Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines.
|
| |
Eur J Biochem, 248,
507-515.
|
 |
|
|
|
|
 |
H.Arai,
C.L.Tsou,
and
I.F.Charo
(1997).
Chemotaxis in a lymphocyte cell line transfected with C-C chemokine receptor 2B: evidence that directed migration is mediated by betagamma dimers released by activation of Galphai-coupled receptors.
|
| |
Proc Natl Acad Sci U S A, 94,
14495-14499.
|
 |
|
|
|
|
 |
J.Lubkowski,
G.Bujacz,
L.Boqué,
P.J.Domaille,
T.M.Handel,
and
A.Wlodawer
(1997).
The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions.
|
| |
Nat Struct Biol, 4,
64-69.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.F.Jerva,
G.Sullivan,
and
E.Lolis
(1997).
Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
|
| |
Protein Sci, 6,
1643-1652.
|
 |
|
|
|
|
 |
M.Baggiolini,
B.Dewald,
and
B.Moser
(1997).
Human chemokines: an update.
|
| |
Annu Rev Immunol, 15,
675-705.
|
 |
|
|
|
|
 |
S.Meunier,
J.M.Bernassau,
J.C.Guillemot,
P.Ferrara,
and
H.Darbon
(1997).
Determination of the three-dimensional structure of CC chemokine monocyte chemoattractant protein 3 by 1H two-dimensional NMR spectroscopy.
|
| |
Biochemistry, 36,
4412-4422.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.R.Leong,
H.B.Lowman,
J.Liu,
S.Shire,
L.E.Deforge,
B.L.Gillece-Castro,
R.McDowell,
and
C.A.Hébert
(1997).
IL-8 single-chain homodimers and heterodimers: interactions with chemokine receptors CXCR1, CXCR2, and DARC.
|
| |
Protein Sci, 6,
609-617.
|
 |
|
|
|
|
 |
C.J.Tsai,
S.L.Lin,
H.J.Wolfson,
and
R.Nussinov
(1996).
Protein-protein interfaces: architectures and interactions in protein-protein interfaces and in protein cores. Their similarities and differences.
|
| |
Crit Rev Biochem Mol Biol, 31,
127-152.
|
 |
|
|
|
|
 |
G.J.Graham,
P.C.Wilkinson,
R.J.Nibbs,
S.Lowe,
S.O.Kolset,
A.Parker,
M.G.Freshney,
M.L.Tsang,
and
I.B.Pragnell
(1996).
Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.
|
| |
EMBO J, 15,
6506-6515.
|
 |
|
|
|
|
 |
R.P.Negus
(1996).
The chemokines: cytokines that direct leukocyte migration.
|
| |
J R Soc Med, 89,
312-314.
|
 |
|
|
|
|
 |
T.M.Handel,
and
P.J.Domaille
(1996).
Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer.
|
| |
Biochemistry, 35,
6569-6584.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.D.Luster,
S.M.Greenberg,
and
P.Leder
(1995).
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.
|
| |
J Exp Med, 182,
219-231.
|
 |
|
|
|
|
 |
A.M.Gronenborn,
and
G.M.Clore
(1995).
Structures of protein complexes by multidimensional heteronuclear magnetic resonance spectroscopy.
|
| |
Crit Rev Biochem Mol Biol, 30,
351-385.
|
 |
|
|
|
|
 |
G.M.Clore,
J.Ernst,
R.Clubb,
J.G.Omichinski,
W.M.Kennedy,
K.Sakaguchi,
E.Appella,
and
A.M.Gronenborn
(1995).
Refined solution structure of the oligomerization domain of the tumour suppressor p53.
|
| |
Nat Struct Biol, 2,
321-333.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.H.Gong,
and
I.Clark-Lewis
(1995).
Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues.
|
| |
J Exp Med, 181,
631-640.
|
 |
|
|
|
|
 |
J.Qin,
G.M.Clore,
W.M.Kennedy,
J.R.Huth,
and
A.M.Gronenborn
(1995).
Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF kappa B.
|
| |
Structure, 3,
289-297.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.E.Strzelecka,
G.M.Clore,
and
A.M.Gronenborn
(1995).
The solution structure of the Mu Ner protein reveals a helix-turn-helix DNA recognition motif.
|
| |
Structure, 3,
1087-1095.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Zhang,
and
B.J.Rollins
(1995).
A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer.
|
| |
Mol Cell Biol, 15,
4851-4855.
|
 |
|
|
|
|
 |
D.G.Covell,
G.W.Smythers,
A.M.Gronenborn,
and
G.M.Clore
(1994).
Analysis of hydrophobicity in the alpha and beta chemokine families and its relevance to dimerization.
|
| |
Protein Sci, 3,
2064-2072.
|
 |
|
|
|
|
 |
F.F.Damberger,
J.G.Pelton,
C.J.Harrison,
H.C.Nelson,
and
D.E.Wemmer
(1994).
Solution structure of the DNA-binding domain of the heat shock transcription factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.
|
| |
Protein Sci, 3,
1806-1821.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Qin,
G.M.Clore,
and
A.M.Gronenborn
(1994).
The high-resolution three-dimensional solution structures of the oxidized and reduced states of human thioredoxin.
|
| |
Structure, 2,
503-522.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.T.Clubb,
J.G.Omichinski,
H.Savilahti,
K.Mizuuchi,
A.M.Gronenborn,
and
G.M.Clore
(1994).
A novel class of winged helix-turn-helix protein: the DNA-binding domain of Mu transposase.
|
| |
Structure, 2,
1041-1048.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.J.Schall,
and
K.B.Bacon
(1994).
Chemokines, leukocyte trafficking, and inflammation.
|
| |
Curr Opin Immunol, 6,
865-873.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|